MLYS insider transactions

SEC Form 4 filed by Rodman David Malcom

SEC Form 4 filed by Rodman David Malcom

SEC Form 4 filed by Congleton Jon

SEC Form 4 filed by Rodman David Malcom

SEC Form 4 filed by Congleton Jon

SEC Form 4 filed by Karydas Daphne

SEC Form 4 filed by Ra Capital Management, L.P.

Chief Medical Officer Rodman David Malcom sold $10,696 worth of shares (417 units at $25.65) and exercised 417 shares at a strike of $15.44 (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 14,057 shares at a strike of $7.28 and sold $542,973 worth of shares (20,406 units at $26.61), decreasing direct ownership by 8% to 76,140 units (SEC Form 4)

SEC Form 4 filed by Mineralys Therapeutics Inc.

New insider Warren Eric claimed ownership of 38,400 shares (SEC Form 3)

Director Ra Capital Management, L.P. was granted 6,200 shares (SEC Form 4)

Director Sblendorio Glenn was granted 6,200 shares (SEC Form 4)

Chief Executive Officer Congleton Jon was granted 140,900 shares, increasing direct ownership by 22% to 780,051 units (SEC Form 4)

Director Gold Alexander M was granted 6,200 shares (SEC Form 4)

Director Karydas Daphne was granted 6,200 shares (SEC Form 4)

Director Slingsby Brian Taylor was granted 6,200 shares, disposed of 6,200 shares and acquired 6,200 shares (SEC Form 4)

Director Akkaraju Srinivas was granted 6,200 shares (SEC Form 4)

Director Dirocco Derek was granted 6,200 shares (SEC Form 4)

CFO and Secretary Levy Adam Scott was granted 39,900 shares, increasing direct ownership by 462% to 48,538 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom was granted 38,400 shares, increasing direct ownership by 87% to 82,489 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 417 shares at a strike of $15.44 and sold $11,505 worth of shares (417 units at $27.59) (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 14,056 shares at a strike of $7.28 and sold $569,809 worth of shares (20,404 units at $27.93), decreasing direct ownership by 13% to 44,089 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 2,171 shares at a strike of $16.00 and sold $65,586 worth of shares (2,171 units at $30.21) (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 416 shares at a strike of $15.44 and sold $13,354 worth of shares (416 units at $32.10) (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 7,709 shares at a strike of $12.39 and sold $623,115 worth of shares (19,076 units at $32.66), decreasing direct ownership by 18% to 50,437 units (SEC Form 4)

Chief Executive Officer Congleton Jon sold $529,640 worth of shares (16,236 units at $32.62), decreasing direct ownership by 2% to 639,151 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 8,518 shares at a strike of $4.88 and sold $277,339 worth of shares (8,518 units at $32.56) (SEC Form 4)

CFO and Secretary Levy Adam Scott sold $345,723 worth of shares (10,758 units at $32.14), decreasing direct ownership by 55% to 8,638 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 252,721 shares at a strike of $12.27 and sold $9,261,028 worth of shares (262,752 units at $35.25), decreasing direct ownership by 14% to 61,804 units (SEC Form 4)

Chief Executive Officer Congleton Jon exercised 24,082 shares at a strike of $0.54, increasing direct ownership by 4% to 655,387 units (SEC Form 4)

Director Slingsby Brian Taylor sold $43,350,000 worth of shares (1,000,000 units at $43.35) (SEC Form 4)

CFO and Secretary Levy Adam Scott exercised 105,653 shares at a strike of $14.11 and sold $5,363,716 worth of shares (119,524 units at $44.88), decreasing direct ownership by 42% to 19,396 units (SEC Form 4)

Chief Executive Officer Congleton Jon sold $9,088,499 worth of shares (200,000 units at $45.44), decreasing direct ownership by 24% to 631,305 units (SEC Form 4)

Director Karydas Daphne exercised 15,000 shares at a strike of $10.20 and sold $689,797 worth of shares (15,000 units at $45.99) (SEC Form 4)

Director Gold Alexander M exercised 34,675 shares at a strike of $10.92 and sold $1,576,095 worth of shares (34,675 units at $45.45) (SEC Form 4)

CFO and Secretary Levy Adam Scott sold $451,984 worth of shares (10,758 units at $42.01), decreasing direct ownership by 8% to 116,865 units (SEC Form 4)

Chief Executive Officer Congleton Jon sold $644,327 worth of shares (15,100 units at $42.67), decreasing direct ownership by 2% to 831,305 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom sold $445,982 worth of shares (10,369 units at $43.01), decreasing direct ownership by 13% to 71,155 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom sold $409,266 worth of shares (11,367 units at $36.00), decreasing direct ownership by 12% to 81,524 units (SEC Form 4)

Director Akkaraju Srinivas bought $14,999,992 worth of shares (588,235 units at $25.50) (SEC Form 4)

Director Ra Capital Management, L.P. bought $29,999,985 worth of shares (1,176,470 units at $25.50) (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 6,349 shares at a strike of $1.08 and sold $146,987 worth of shares (11,365 units at $12.93), decreasing direct ownership by 5% to 92,891 units (SEC Form 4)

CFO and Secretary Levy Adam Scott sold $1,077,477 worth of shares (73,678 units at $14.62), decreasing direct ownership by 36% to 132,934 units (SEC Form 4)

Chief Executive Officer Congleton Jon sold $230,431 worth of shares (15,884 units at $14.51), decreasing direct ownership by 2% to 846,405 units (SEC Form 4)

CFO and Secretary Levy Adam Scott sold $155,454 worth of shares (10,758 units at $14.45), decreasing direct ownership by 5% to 206,612 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 6,349 shares at a strike of $1.08 and sold $165,879 worth of shares (11,366 units at $14.59), decreasing direct ownership by 5% to 97,907 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 6,348 shares at a strike of $1.08 and sold $165,931 worth of shares (11,366 units at $14.60), decreasing direct ownership by 5% to 101,651 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom sold $173,774 worth of shares (11,366 units at $15.29), decreasing direct ownership by 10% to 106,669 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 6,349 shares at a strike of $1.08, increasing direct ownership by 6% to 118,035 units (SEC Form 4)

Director Slingsby Brian Taylor bought $3,499,996 worth of shares (259,259 units at $13.50) (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 6,348 shares at a strike of $1.08 and sold $165,185 worth of shares (11,366 units at $14.53), decreasing direct ownership by 4% to 111,686 units (SEC Form 4)

CFO and Secretary Levy Adam Scott sold $129,684 worth of shares (10,757 units at $12.06), decreasing direct ownership by 5% to 215,340 units (SEC Form 4)

Chief Executive Officer Congleton Jon sold $186,803 worth of shares (15,319 units at $12.19), decreasing direct ownership by 2% to 862,289 units (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 1,606 shares at a strike of $1.08 and sold $879,008 worth of shares (55,771 units at $15.76), decreasing direct ownership by 32% to 116,704 units (SEC Form 4)

Large owner Samsara Biocapital Gp, Llc bought $8,100,000 worth of shares (600,000 units at $13.50) (SEC Form 4)

Director Akkaraju Srinivas bought $8,100,000 worth of shares (600,000 units at $13.50) (SEC Form 4)

Director Ra Capital Management, L.P. bought $17,499,996 worth of shares (1,296,296 units at $13.50) (SEC Form 4)

Chief Medical Officer Rodman David Malcom exercised 6,349 shares at a strike of $1.08, increasing direct ownership by 4% to 170,869 units (SEC Form 4)

SEC Form 4 filed by Director Ra Capital Management, L.P.